Avoro Capital Advisors LLC Diversified Active

Location: New York, NY

CIK: 0001633313 · Show all filings

Period: Q4 2014 (Next →)

Filing Date: Feb 13, 2015

Total Value: $148M (98.4% shares, 1.6% debt)

Holdings (30)

FOLD AMICUS THERAPEUTICS INC 15.9%

Value $23.5M Shares 2,824,185 Est. Cost $6.86 Unrealized 0.0%

— TARO PHARMACEUTICAL INDUS 8.4%

Value $12.42M Shares 83,800 Est. Cost $148.19 Unrealized —

— RECEPTOS INC 7.3%

Value $10.72M Shares 87,500 Est. Cost $122.51 Unrealized —

— PERNIX THERAPEUTICS HOLDINGS 7.2%

Value $10.65M Shares 1,134,578 Est. Cost $9.39 Unrealized —

— AGENUS - INC 7.1%

Value $10.47M Shares 2,638,071 Est. Cost $3.97 Unrealized —

SRNE SORRENTO THERAPEUTICS INC 6.2%

Value $9.165M Shares 910,100 Est. Cost $5.07 Unrealized 0.0%

EBS EMERGENT BIOSOLUTIONS INC 6.1%

Value $9.003M Shares 330,635 Est. Cost $23.83 Unrealized 0.0%

— MACROGENICS INC. 3.9%

Value $5.699M Shares 162,500 Est. Cost $35.07 Unrealized —

— ONCOTHYREON INC 3.9%

Value $5.684M Shares 2,991,636 Est. Cost $1.90 Unrealized —

— BELLICUM PHARMACEUTICALS INC 3.4%

Value $5.069M Shares 220,000 Est. Cost $23.04 Unrealized —

— LA JOLLA PHARMACEUTICAL CO. 3.1%

Value $4.548M Shares 246,499 Est. Cost $18.45 Unrealized —

— IGI LABORATORIES INC 2.8%

Value $4.069M Shares 462,342 Est. Cost $8.80 Unrealized —

— CELGENE CORP. 2.7%

Value $3.924M Shares 150,000 Est. Cost — Unrealized —

— ARROWHEAD RESEARCH - CORP 2.6%

Value $3.875M Shares 525,000 Est. Cost $7.38 Unrealized —

— FLAMEL TECHNOLOGIES 2.5%

Value $3.68M Shares 214,805 Est. Cost $17.13 Unrealized —

— IGNYTA INC. 2.4%

Value $3.57M Shares 521,233 Est. Cost $6.85 Unrealized —

— ALIMERA SCIENCES INC 2.3%

Value $3.389M Shares 674,593 Est. Cost $5.02 Unrealized —

— DYNAVAX TECHNOLOGIES CORP 2.3%

Value $3.361M Shares 199,332 Est. Cost $16.86 Unrealized —

VCEL VERICEL CORP. 2.2%

Value $3.219M Shares 1,058,820 Est. Cost $2.85 Unrealized 0.0%

— EXELIXIS INC EXEL 20190815 4.250000% 1.6%

Value $2.398M Shares 4,250,000 Est. Cost $0.56 Unrealized —

— BIOLASE INC 1.4%

Value $2.063M Shares 784,500 Est. Cost $2.63 Unrealized —

— NOVAVAX INC 1.2%

Value $1.779M Shares 300,000 Est. Cost $5.93 Unrealized —

CPRX CATALYST PHARMACEUTICAL PART.. 1.1%

Value $1.635M Shares 550,670 Est. Cost $2.74 Unrealized 0.0%

— INNOCOLL AG 0.9%

Value $1.335M Shares 225,000 Est. Cost $5.93 Unrealized —

— FORWARD PHARMA A/S-ADR 0.7%

Value $1.042M Shares 50,000 Est. Cost $20.84 Unrealized —

HRTX HERON THERAPEUTICS INC 0.4%

Value $663K Shares 65,900 Est. Cost $8.16 Unrealized 0.0%

— BIOTA PHARMACEUTICALS- INC 0.4%

Value $579K Shares 258,586 Est. Cost $2.24 Unrealized —

— RECEPTOS INC 0.1%

Value $82,000 Shares 20,000 Est. Cost $122.51 Unrealized —

— CUBIST PHARMA-RTS 0.0%

Value $6,000 Shares 141,688 Est. Cost $0.04 Unrealized —

EXAS EXACT SCIENCES CORP. 0.0%

Value $4,000 Shares 9,600 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
FOLD	AMICUS THERAPEUTICS INC	2,824,185	$23.5M	15.9%	$6.86	0.0%	Common	03152W109
—	TARO PHARMACEUTICAL INDUS	83,800	$12.42M	8.4%	$148.19	—	Shares	M8737E108
—	RECEPTOS INC	87,500	$10.72M	7.3%	$122.51	—	Common	756207106
—	PERNIX THERAPEUTICS HOLDINGS	1,134,578	$10.65M	7.2%	$9.39	—	Common	71426V108
—	AGENUS - INC	2,638,071	$10.47M	7.1%	$3.97	—	Common	00847G705
SRNE	SORRENTO THERAPEUTICS INC	910,100	$9.165M	6.2%	$5.07	0.0%	Common	83587F202
EBS	EMERGENT BIOSOLUTIONS INC	330,635	$9.003M	6.1%	$23.83	0.0%	Common	29089Q105
—	MACROGENICS INC.	162,500	$5.699M	3.9%	$35.07	—	Common	556099909
—	ONCOTHYREON INC	2,991,636	$5.684M	3.9%	$1.90	—	Common	682324108
—	BELLICUM PHARMACEUTICALS INC	220,000	$5.069M	3.4%	$23.04	—	Common	079481107
—	LA JOLLA PHARMACEUTICAL CO.	246,499	$4.548M	3.1%	$18.45	—	Common	503459604
—	IGI LABORATORIES INC	462,342	$4.069M	2.8%	$8.80	—	Common	449575109
—	CELGENE CORP.	150,000	$3.924M	2.7%	—	—	Call	151020104
—	ARROWHEAD RESEARCH - CORP	525,000	$3.875M	2.6%	$7.38	—	Common	042797209
—	FLAMEL TECHNOLOGIES	214,805	$3.68M	2.5%	$17.13	—	Sponsored ADR	338488109
—	IGNYTA INC.	521,233	$3.57M	2.4%	$6.85	—	Common	451731103
—	ALIMERA SCIENCES INC	674,593	$3.389M	2.3%	$5.02	—	Common	016259103
—	DYNAVAX TECHNOLOGIES CORP	199,332	$3.361M	2.3%	$16.86	—	Common	268158201
VCEL	VERICEL CORP.	1,058,820	$3.219M	2.2%	$2.85	0.0%	Common	92346J108
—	EXELIXIS INC EXEL 20190815 4.250000%	4,250,000	$2.398M	1.6%	$0.56	—	Notes	30161QAC8
—	BIOLASE INC	784,500	$2.063M	1.4%	$2.63	—	Common	090911108
—	NOVAVAX INC	300,000	$1.779M	1.2%	$5.93	—	Common	670002104
CPRX	CATALYST PHARMACEUTICAL PART..	550,670	$1.635M	1.1%	$2.74	0.0%	Common	14888U101
—	INNOCOLL AG	225,000	$1.335M	0.9%	$5.93	—	Sponsored ADR	45780Q103
—	FORWARD PHARMA A/S-ADR	50,000	$1.042M	0.7%	$20.84	—	Sponsored ADR	34986J105
HRTX	HERON THERAPEUTICS INC	65,900	$663K	0.4%	$8.16	0.0%	Common	427746102
—	BIOTA PHARMACEUTICALS- INC	258,586	$579K	0.4%	$2.24	—	Common	090694100
—	RECEPTOS INC	20,000	$82,000	0.1%	$122.51	—	Put	756207106
—	CUBIST PHARMA-RTS	141,688	$6,000	0.0%	$0.04	—	Rights	229678123
EXAS	EXACT SCIENCES CORP.	9,600	$4,000	0.0%	—	—	Put	30063P105